Stockscreener 앱 받기
3.6822
2.07%
-0.0778
시간 외 거래:
3.68
-0.00218
-0.06%
전일 마감가:
$3.76
열려 있는:
$3.76
하루 거래량:
22,322
Relative Volume:
1.75
시가총액:
$42.18M
수익:
$10.96M
순이익/손실:
$-7.02M
주가수익비율:
-5.8447
EPS:
-0.63
순현금흐름:
$-3.72M
1주 성능:
-4.41%
1개월 성능:
-25.84%
6개월 성능:
-37.38%
1년 성능:
-31.17%
1일 변동 폭
$3.65
$3.87
1주일 범위
$3.65
$4.00
52주 변동 폭
$3.65
$6.99
Collplant Biotechnologies Ltd Stock (CLGN) Company Profile
Collplant Biotechnologies Ltd Stock (CLGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-02-17 | 개시 | Alliance Global Partners | Buy |
Collplant Biotechnologies Ltd 주식(CLGN)의 최신 뉴스
Collplant stock hits 52-week low at $3.75 amid market challenges - Investing.com UK
EF Hutton Initiates Coverage of CollPlant Biotechnologies (CLGN) with Buy Recommendation - MSN
Collplant stock hits 52-week low at $4.05 amid market challenges - Investing.com India
Collplant stock hits 52-week low at $4.05 amid market challenges By Investing.com - Investing.com South Africa
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Short Interest Update - Defense World
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Short Interest Up 5.3% in September - MarketBeat
Benjamin F. Edwards & Company Inc. Sells 10,690 Shares of CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) - Defense World
CollPlant Shareholders Approve Key Proposals - TipRanks
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Sees Large Growth in Short Interest - MarketBeat
CollPlant (CLGN), Stratasys Initiate Study for Breast Implants - MSN
CollPlant and Stratasys Launch Pre-clinical Trial for Regenerative 3D-Printed Breast Implants - 3DPrint.com
The Stratasys’ Origin® printer to be tested for CollPlant’s 3D-printed breast implants - 3d adept media
HC Wainwright Weighs in on CollPlant Biotechnologies Ltd.'s Q3 2024 Earnings (NASDAQ:CLGN) - MarketBeat
Head-To-Head Analysis: Envoy Medical (NASDAQ:COCH) and CollPlant Biotechnologies (NASDAQ:CLGN) - Defense World
HC Wainwright Weighs in on CollPlant Biotechnologies Ltd.’s Q3 2024 Earnings (NASDAQ:CLGN) - Defense World
FY2027 EPS Estimates for CollPlant Biotechnologies Ltd. Reduced by HC Wainwright (NASDAQ:CLGN) - MarketBeat
HC Wainwright Research Analysts Cut Earnings Estimates for CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) - Defense World
Global Tooth Regeneration Market Size To Worth USD 8.20 Billion By 2033 | CAGR Of 6.18% - GlobeNewswire Inc.
CollPlant Schedules Shareholder Meeting - Investing.com India
CollPlant Schedules Shareholder Meeting By Investing.com - Investing.com Australia
Cracking The Code: Understanding Analyst Reviews For CollPlant Biotechnologies - Benzinga
CollPlant Biotechnologies’ (CLGN) Buy Rating Reaffirmed at HC Wainwright - Defense World
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q2 2024 Earnings Call Transcript - Insider Monkey
Earnings call: CollPlant Biotechnologies reports Q2 2024 financials By Investing.com - Investing.com Australia
CollPlant Biotechnologies Ltd (CLGN) Q2 2024 Earnings Call Trans - GuruFocus.com
Q2 2024 Collplant Biotechnologies Ltd Earnings Call Transcript - GuruFocus.com
CollPlant Announces Upcoming Shareholder Meeting - TipRanks
Collplant stock hits 52-week low at $4.1 amid market challenges - Investing.com
Even after rising 10% this past week, CollPlant Biotechnologies (NASDAQ:CLGN) shareholders are still down 71% over the past three years - Yahoo Finance
COLLPLANT BIOTECHNOLOGIES REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - Nasdaq
We're Interested To See How CollPlant Biotechnologies (NASDAQ:CLGN) Uses Its Cash Hoard To Grow - Simply Wall St
CollPlant and Stratasys launch pre-clinical study for 3D implants - Investing.com India
CollPlant Biotechnologies (FRA:CPT) Earnings per Share (Dil - GuruFocus.com
CollPlant Biotechnologies (FRA:CPT) Cash Flow for Lease Fin - GuruFocus.com
CollPlant Biotechnologies (FRA:CPT) Market Cap : €48.54 Mil (As of Aug. 19, 2024) - GuruFocus.com
CollPlant and Stratasys announce pre-clinical study for regenerative breast implants - Med-Tech Innovation
Stratasys and CollPlant commence pre-clinical study for 3D printed regenerative breast implants - TCT Magazine
CollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast Implants - Lelezard
CollPlant Biotechnologies (FRA:CPT) Cash Flow from Financin - GuruFocus.com
CollPlant Biotechnologies (FRA:CPT) Cash-to-Debt : 7.69 (As of Mar. 2024) - GuruFocus.com
CollPlant Biotechnologies (FRA:CPT) Machinery, Furniture, E - GuruFocus.com
CLGN (CollPlant Biotechnologies) Debt-to-Revenue : 7.70 (As of Mar. 2024) - GuruFocus.com
CLGN (CollPlant Biotechnologies) EV-to-Revenue : 3.11 (As of Aug. 18, 2024) - GuruFocus.com
CLGN (CollPlant Biotechnologies) 14-Day RSI : 48.58 (As of Aug. 18, 2024) - GuruFocus.com
CollPlant Biotechnologies (FRA:CPT) Long-Term Debt & Capita - GuruFocus.com
CollPlant Biotechnologies (FRA:CPT) Earnings Yield % : N/A% (As of Aug. 17, 2024) - GuruFocus.com
CollPlant Biotechnologies (FRA:CPT) Accounts Receivable : €0.08 Mil (As of Mar. 2024) - GuruFocus.com
CollPlant Biotechnologies (FRA:CPT) Change In Receivables : €0.34 Mil (TTM As of Mar. 2024) - GuruFocus.com
CollPlant Biotechnologies (FRA:CPT) Inventory Turnover : 0.80 (As of Mar. 2024) - GuruFocus.com
CollPlant Biotechnologies (FRA:CPT) Free Cash Flow per Shar - GuruFocus.com
CollPlant Biotechnologies (FRA:CPT) Preferred Stock : €0.00 Mil (As of Mar. 2024) - GuruFocus.com
Collplant Biotechnologies Ltd (CLGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.11%
0.26%
자본화:
|
볼륨(24시간):